Congenital hepatic fibrosis in autosomal recessive polycystic kidney disease
- PMID: 22212229
- PMCID: PMC3252199
- DOI: 10.1111/j.1752-8062.2011.00306.x
Congenital hepatic fibrosis in autosomal recessive polycystic kidney disease
Abstract
Autosomal recessive polycystic kidney disease (ARPKD) is a developmental disorder that mainly affects the kidneys and the biliary tract. Affected patients often have massively enlarged cystic kidneys as well as congenital hepatic fibrosis (CHF) characterized by dilated bile ducts and associated peribiliary fibrosis. This review will examine what is known about ARPKD-associated liver disease and will highlight areas of ongoing research into its pathogenesis and potential treatment.
© 2011 Wiley Periodicals, Inc.
Figures
References
-
- Dias NF, Lanzarini V, Onuchic LF, Koch VH. Clinical aspects of autosomal recessive polycystic kidney disease. J Bras Nefrol. 2010; 32(3): 263–267. - PubMed
-
- Guay‐Woodford LM, Desmond RA. Autosomal recessive polycystic kidney disease: the clinical experience in North America. Pediatrics. 2003; 111(5 Pt 1): 1072–1080. - PubMed
-
- Gunay‐Aygun M, Tuchman M, Font‐Montgomery E, Lukose L, Edwards H, Garcia A, Ausavarat S, Ziegler SG, Piwnica‐Worms K, Bryant J, et al PKHD1 sequence variations in 78 children and adults with autosomal recessive polycystic kidney disease and congenital hepatic fibrosis. Mol Genet Metab. 2010; 99(2): 160–173. - PMC - PubMed
-
- Zerres K, Mucher G, Becker J, Steinkamm C, Rudnik‐Schoneborn S, Heikkila P, Rapola J, Salonen R, Germino GG, Onuchic L, et al Prenatal diagnosis of autosomal recessive polycystic kidney disease (ARPKD): molecular genetics, clinical experience, and fetal morphology. Am J Med Genet. 1998; 76(2): 137–144. - PubMed
-
- Zerres K, Rudnik‐Schoneborn S, Steinkamm C, Becker J, Mucher G. Autosomal recessive polycystic kidney disease. J Mol Med. 1998; 76(5): 303–309. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
